[Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)]. 1979

T Zmorski, and R Unterrassner

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003006 Clopenthixol A thioxanthene with therapeutic actions similar to the phenothiazine antipsychotics. It is an antagonist at D1 and D2 dopamine receptors. Cisordinol,Zuclopenthixol,alpha-Clopenthixol,alpha Clopenthixol
D003651 Decanoates Salts and esters of the 10-carbon monocarboxylic acid-decanoic acid.
D003652 Decanoic Acids 10-carbon saturated monocarboxylic acids. Capric Acids,Acids, Capric,Acids, Decanoic
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

T Zmorski, and R Unterrassner
January 1982, International pharmacopsychiatry,
T Zmorski, and R Unterrassner
April 1977, Acta pharmacologica et toxicologica,
T Zmorski, and R Unterrassner
July 1978, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
T Zmorski, and R Unterrassner
January 1963, Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
T Zmorski, and R Unterrassner
January 1962, Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry,
T Zmorski, and R Unterrassner
January 1981, Acta psychiatrica Scandinavica. Supplementum,
T Zmorski, and R Unterrassner
July 1962, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!